Related Experiment Video
Updated: May 3, 2026
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Clinical update on cancer: molecular oncology of head and neck cancer
Y Suh1, I Amelio2, T Guerrero Urbano3
1Department of Molecular Oncology, King's College London, Guy's Hospital, Hodgkin Building, London SE1 1NU, UK.
Abstract:
Head and neck cancers encompass a heterogeneous group of tumours that, in general, are biologically aggressive in nature. These cancers remain difficult to treat and treatment can cause severe, long-term side effects. For patients who are not cured by surgery and/or (chemo)radiotherapy, there are few effective treatment options. Targeted therapies and predictive biomarkers are urgently needed in order to improve the management and minimise the treatment toxicity, and to allow selection of patients who are likely to benefit from both nonselective and targeted therapies. This clinical update aims to provide an insight into the current understanding of the molecular pathogenesis of the disease, and explores the novel therapies under development and in clinical trials.
Insights
Targeted therapies and predictive biomarkers are crucial for improving head and neck cancer treatment outcomes. This research explores novel treatments to enhance patient selection and minimize side effects.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Head and neck cancers are aggressive and challenging to treat.
- Current treatments often cause severe, long-term side effects.
- Limited options exist for patients resistant to standard therapies.
Purpose of the Study:
- To provide insight into the molecular pathogenesis of head and neck cancers.
- To explore novel therapies currently in development and clinical trials.
- To highlight the need for targeted therapies and predictive biomarkers.
Main Methods:
- Review of current literature on molecular pathogenesis.
- Analysis of ongoing clinical trials for novel therapies.
- Discussion of predictive biomarker strategies.
Main Results:
- Head and neck cancers exhibit complex molecular heterogeneity.
- Emerging targeted therapies show promise in early-stage trials.
- Biomarker research is essential for personalized treatment selection.
Conclusions:
- Targeted therapies and predictive biomarkers are vital for advancing head and neck cancer management.
- Personalized treatment approaches can improve efficacy and reduce toxicity.
- Further research into molecular drivers and novel agents is warranted.
More Related Videos
07:44Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
Published on: April 3, 2026
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
02:18Cancer
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...